Professional paper
ANTIMICROBIAL RESISTANCE OF STAPHYLOCOCCUS AUREUS ISOLATES FROM CROATIA IN YEAR 2004
Ana Budimir
; Department of clinical and molecular microbiology, Clinical hospital center Zagreb, Croatia
Zrinka Bošnjak
; Department of clinical and molecular microbiology, Clinical hospital center Zagreb, Croatia
Smilja Kalenić
; Department of clinical and molecular microbiology, Clinical hospital center Zagreb, Croatia
Tera Tambić
; Academy of medical sciences, Department of Public Health, Zagreb, Croatia
Arjana Tambić Andrašević
; Clinic for Infectious Diseases "F.Mihaljević", Zagreb, Croatia
članovi Odbora za praćenje otpornosti bakterija na antibiotike u Republici Hrvatskoj
Abstract
Study goal: As a part of annual resistance surveillance coordinated by Croatian academy of medical sciences, study on resistance of Staphylococcus aureus isolates to antimicrobial drugs was performed together with analysis of origin of strains and number of strains isolated
from different body sites.
Methods: During last three months of 2004 (October till December), succesive Staphylococcus aureus isolates were collected from 27 laboratories in 20 Croatian cities. Strains were sent to Department of clinical and molecular microbiology in CHC Zagreb with accompanying form containing patient data, diagnosis, hospital stay and other epidemiological data. During that period, 1815 isolates were collected and sensitivity testing to 18 antimicrobial drugs was performed according to CLSI guidelines and interpretation standards, and interpretation of BSAC for mupirocin and fucidic acid.
Results and conclusion: Collection of S. aureus isolates presents majority of Croatian isolates in study period, therefore susceptibility results are representative of Croatia. 48% of SA is isolated from nasal/nasopharyngeal swabs, wound swab percentage is 27%, sputum is and lower respiratory tract specimen is respresented with 9% of isolates, percentage of blood and CSF isolates is 4%. MRSA prevalence varies from 0% to 47.6%.
Keywords
Staphylococcus aureus; resistance; antibiotics; community-acquired MRSA
Hrčak ID:
23337
URI
Publication date:
20.3.2007.
Visits: 2.601 *